Commonwealth Equity Services
CTXR icon

Commonwealth Equity Services’s Citius Pharmaceuticals CTXR Stock Holding History

Commonwealth Equity Services’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,130
Closed -$19K – 3932
2023
Q3 		$19K Hold
1,130
– – ﹤0.01% 3737
2023
Q2 		$34K Hold
1,130
– – ﹤0.01% 3707
2023
Q1 		$33 Hold
1,130
– – ﹤0.01% 3621
2022
Q4 		$22K Buy
1,130
+8
+0.7% +$218 ﹤0.01% 3590
2022
Q3 		$33K Hold
1,122
– – ﹤0.01% 3523
2022
Q2 		$25K Hold
1,122
– – ﹤0.01% 3553
2022
Q1 		$50K Sell
1,122
-12
-1% -$474 ﹤0.01% 3580
2021
Q4 		$43K Sell
1,134
-239
-17% -$10.8K ﹤0.01% 3551
2021
Q3 		$69K Buy
+1,373
New +$68.9K ﹤0.01% 3465

Other funds holding CTXR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Commonwealth Equity Services's CTXR Position: Q4 2023 in Review

Commonwealth Equity Services sold out of Citius Pharmaceuticals (CTXR) in Q4 2023, closing a stake of 1,130 shares — an estimated $19K sold.

Commonwealth Equity Services first reported a position in CTXR in Q3 2021 and held it in 9 quarters. The position peaked at $69K in Q3 2021. 74 funds tracked by Wall St. Rank hold CTXR as of Q4 2023.

  • Commonwealth Equity Services reported no remaining Citius Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,130 Citius Pharmaceuticals shares in Q4 2023, an estimated $19K.
  • Commonwealth Equity Services first reported a position in Citius Pharmaceuticals in Q3 2021 and held it in 9 quarters.
  • Commonwealth Equity Services's Citius Pharmaceuticals position peaked at $69K in Q3 2021.
  • 74 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2023.

Based on Commonwealth Equity Services's 13F filing for Q4 2023, filed 6 Feb 2024.